Home › Carcinoma polmonare a piccole cellule › Oregon › Portland
Studi clinici su Carcinoma polmonare a piccole cellule a Portland, OR
8 studi su Carcinoma polmonare a piccole cellule cercano partecipanti presso sedi a Portland e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- Oregon Health & Science University (OHSU), Portland
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
In reclutamentoFase 3
- Oregon Health and Science University /ID# 280071, Portland
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
In reclutamentoFase 1/2
- Providence Portland Medical Center ( Site 1101), Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Providence Cancer Institute, Portland
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
In reclutamentoFase 3
- Providence Portland Medical Center, Portland
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
In reclutamentoFase 1/2
- Providence Portland Medical Center, Portland
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
In reclutamentoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · a 12 mi di distanza
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
In reclutamentoFase 1
- Oregon Health & Science University, Portland
Studi su Carcinoma polmonare a piccole cellule in altre città
- Houston, TX26 studi
- Arlington, VA23 studi
- Boston, MA21 studi
- New York City, NY21 studi
- Nashville, TN20 studi
- Los Angeles, CA20 studi
- Orlando, FL15 studi
- Dallas, TX13 studi
- St. Louis, MO13 studi
- Cleveland, OH13 studi
- Detroit, MI12 studi
- Chicago, IL12 studi
Altri studi a Portland
- Cancro del polmone non a piccole cellule46 studi
- Cancro (tutti i tipi)34 studi
- Cancro alla prostata33 studi
- Cancro al seno33 studi
- Cancro metastatico29 studi
- Cancro colorettale28 studi
- Cancro ovarico27 studi
- Cancro ai polmoni26 studi
- Leucemia mieloide acuta25 studi
- Cancro dell'endometrio24 studi
- Carcinoma a cellule squamose della testa e del collo19 studi
- Cancro pancreatico19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.